1. Zhang, Jun, Lyu, Zhuwan, Li, Bo, Xiao, Xiao, Ma, Xiong. 2023. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. In Hepatology (Baltimore, Md.), 78, 10-25. doi:10.1097/HEP.0000000000000317. https://pubmed.ncbi.nlm.nih.gov/36799463/
2. Zhang, Zhechuan, Zhang, Yuanfeng, Zhang, Ronggui. 2023. P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway. In Medical oncology (Northwood, London, England), 40, 70. doi:10.1007/s12032-022-01926-2. https://pubmed.ncbi.nlm.nih.gov/36588128/
3. Zhou, Hailang, Zou, Junwei, Han, Jingli, Zhou, Aijun, Huang, Shu. 2024. P4HA3 promotes colon cancer cell escape from macrophage phagocytosis by increasing phagocytosis immune checkpoint CD47 expression. In Molecular and cellular biochemistry, 479, 3355-3374. doi:10.1007/s11010-024-04927-z. https://pubmed.ncbi.nlm.nih.gov/38347264/
4. Yu, Chunlai, You, Mingliang, Zhang, Peizhen, Yin, Yuzhu, Zhang, Xiao. 2021. A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix. In Cancer medicine, 10, 4629-4643. doi:10.1002/cam4.3986. https://pubmed.ncbi.nlm.nih.gov/34121340/
5. Xiao, Zezhou, Reddy, Desai Pavan Kumar, Xue, Chuqing, Ling, Xiao, Zheng, Shaoyi. 2021. Profiling of miR-205/P4HA3 Following Angiotensin II-Induced Atrial Fibrosis: Implications for Atrial Fibrillation. In Frontiers in cardiovascular medicine, 8, 609300. doi:10.3389/fcvm.2021.609300. https://pubmed.ncbi.nlm.nih.gov/33981730/
6. Shi, Run, Gao, Shanshan, Zhang, Jie, Yang, Xiaowen, Li, Chaoyang. . Collagen prolyl 4-hydroxylases modify tumor progression. In Acta biochimica et biophysica Sinica, 53, 805-814. doi:10.1093/abbs/gmab065. https://pubmed.ncbi.nlm.nih.gov/34009234/
7. Wang, Quannian, Meng, Danyang, Shen, Si, Shao, Changli, Dong, Qingyang. 2024. P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway. In Pathology, research and practice, 260, 155481. doi:10.1016/j.prp.2024.155481. https://pubmed.ncbi.nlm.nih.gov/39053135/
8. Zhou, Hailang, Zou, Junwei, Shao, Changjiang, Chen, Song, Xu, Chunfang. 2021. Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway. In Pathology, research and practice, 230, 153749. doi:10.1016/j.prp.2021.153749. https://pubmed.ncbi.nlm.nih.gov/34959098/
9. Wu, Yinteng, Zhang, Bo, Nong, Juan, Zhao, Shijian, Wei, Ruqiong. 2023. Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3. In Frontiers in genetics, 14, 1045061. doi:10.3389/fgene.2023.1045061. https://pubmed.ncbi.nlm.nih.gov/37035741/
10. Niu, Xiaoji, Ren, Liman, Wang, Shoumei, Qi, Hongjun, Zhang, Shuhui. 2022. High Prolyl 4-Hydroxylase Subunit Alpha 3 Expression as an Independent Prognostic Biomarker and Correlated With Immune Infiltration in Gastric Cancer. In Frontiers in genetics, 13, 952335. doi:10.3389/fgene.2022.952335. https://pubmed.ncbi.nlm.nih.gov/35846138/